| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.63 | 20 |
| GSM780708 | Untreated after 4 days (C2_1) | 40.5432 | 8 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.006 | 32 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.8013 | 17 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.241 | 28 |
| GSM780721 | Untreated after 4 days (C3_2) | 39.8126 | 6 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 39.6693 | 6 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 36.0023 | 1 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 41.0761 | 10 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.9445 | 13 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 38.6189 | 3 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 41.2918 | 10 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 40.1275 | 7 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 36.3329 | 1 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.9503 | 27 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.6115 | 12 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 41.9209 | 13 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 38.9034 | 4 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.4224 | 39 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.0518 | 27 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.2394 | 23 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 39.2875 | 5 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 34.8888 | 1 |